HiteJinro Co Ltd (000087)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 12,130.00 |
|---|---|
| 52-week range | 11,950.00 – 15,580.00 |
| Return, 1 month / 3 months | −1.5% / −1.4% |
| Return, 1 year / 3 years | −21.7% / −10.1% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 9.0% |
| Worst drawdown (1 year) | -22.1% |
| Average daily value traded | 19.68M KRW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
HiteJinro Co Ltd is a Korean beverage company based in Seoul. It makes and sells alcoholic drinks, chiefly beer under its Hite brands and soju, the clear distilled spirit popular in Korea, including its Chamisul label. Its customers are drinkers in Korea and in overseas markets where Korean spirits and beer are sold, and it supplies restaurants, bars, shops and distributors. The company also produces other beverages and related products alongside its core beer and soju lines.
On this site HiteJinro Co Ltd appears as a stock on the Korea Stock Exchange (Korea), code 000087, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
HiteJinro Co Ltd (000087) trades on the Korea Stock Exchange in Korea. It last closed at KRW 12,130.00 on 23 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 288 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.7% and over the last three months it fell 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -8.9% | ||
| From 52-week high | -21.9% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.4% | ||
| 6-month return | -13.5% | ||
| 12-month return, skipping the last month | -20.6% | ||
| Stability (higher is calmer) | 96 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 9.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.1% | ||
| Liquidity | 5 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 19.68M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −1.5% |
| 3 months | −1.4% |
| 6 months | −13.5% |
| 1 year | −21.7% |
| 3 years | −10.1% |
| 5 years | −27.5% |
Signals
| 50-day / 200-day average | 12,335.80 / 13,318.15 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 222.62 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Dec 2024 | KRW 750.0000 |
| 27 Dec 2023 | KRW 1,000.0000 |
| 28 Dec 2022 | KRW 1,000.0000 |
| 29 Dec 2021 | KRW 850.0000 |
| 29 Dec 2020 | KRW 800.0000 |
| 27 Dec 2019 | KRW 750.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.